A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Intravenous Dose of CBR-2092 in Healthy Volunteers (CBR-2092-001)

Authors

Jeffrey L. Huston, Cedarville UniversityFollow

Role

Lead Pharmacist

Sponsor

Cumbre Pharmaceuticals, Inc.

Location

Dallas, TX

Recommended Citation

Huston, Jeffrey L., "A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Intravenous Dose of CBR-2092 in Healthy Volunteers (CBR-2092-001)" (2006). Pharmacy Faculty Research. 15.
https://digitalcommons.cedarville.edu/pharmacy_research/15